As I expected $PFE $SGMO SB-525 not different from $BMRN valrox for data up to similar time point at the moment. In fact at week 28, the latest week all patients from both programs with data, SB-525 both mean (~65) and median (~55) actually lower than Valrox (both above 70). https://t.co/mqOohPmhqS https://t.co/OHeuA7hqJw